Durgical
EN
Open the app

Thrombophilias: inherited, acquired and antiphospholipid syndrome, and when to test

  • Look-alikes compared

Some people clot more easily because of their genes or another illness. Testing helps only when the result would change what is done.

Updated

What it is

A thrombophilia is an inherited or acquired tendency to form clots. The inherited ones are factor V Leiden (factor V that resists switching off by activated protein C), the prothrombin gene variant (too much prothrombin) and deficiencies of the natural anticoagulants antithrombin, protein C and protein S. Acquired ones include antiphospholipid syndrome (APS), cancer, myeloproliferative neoplasms, paroxysmal nocturnal haemoglobinuria (PNH), nephrotic syndrome, oestrogens, pregnancy and HIT. Most inherited thrombophilias raise risk only modestly; antithrombin deficiency and APS are the important exceptions.

The difference in one line

  • Factor V Leiden is the commonest inherited thrombophilia in people of European ancestry; its frequency varies with ancestry.
  • Antithrombin deficiency carries the highest inherited risk and can make heparin work poorly.
  • Protein C deficiency predisposes to warfarin-induced skin necrosis; severe inherited deficiency causes purpura fulminans in newborns.
  • APS needs both a clinical event (venous or arterial clot, or pregnancy loss or complications) and an antiphospholipid antibody (lupus anticoagulant, anticardiolipin, anti-beta2 glycoprotein I) positive on two tests at least 12 weeks apart.
  • Testing for MTHFR variants or homocysteine does not help in managing venous clots.

Thrombophilias side by side

ConditionMechanismTest and when it misleadsWhat it changes
Factor V LeidenFactor V resists activated protein C (accelerator)Genetic test; reliable at any timeRarely the length of treatment; oestrogen advice
Prothrombin gene variantToo much prothrombin (accelerator)Genetic test; reliable at any timeAs for factor V Leiden
Antithrombin deficiencyWeak brake on thrombin and XaActivity level; falls during a clot and on heparinHigher risk; heparin may work poorly; pregnancy prophylaxis
Protein C or S deficiencyWeak brake on factors V and VIIIActivity levels; fall during a clot, on warfarin, in pregnancy (protein S), in liver diseaseWarfarin start with heparin cover; pregnancy plans
Antiphospholipid syndromeAntibodies activate platelets, endothelium and placentaLupus anticoagulant is distorted by anticoagulants; repeat at 12 weeksWarfarin rather than DOACs in high risk; pregnancy treatment
Acquired states (cancer, MPN, PNH, nephrotic syndrome)Tumour factors, abnormal cells, complement, urinary loss of antithrombinCount, smear, JAK2, flow cytometry for PNH, urine proteinTreat the disease; length and choice of anticoagulant

In clinical practice

  • Think of APS in a young patient with a stroke or clot, recurrent pregnancy loss, low platelets or a long aPTT that does not correct.
  • Clots in unusual places (brain, liver, gut veins) point to MPN, PNH, APS or cancer rather than an inherited thrombophilia.
  • After a clot provoked by major surgery, testing rarely changes anything: the trigger explains it and treatment stops after the usual course.
  • Women with a strong family history of antithrombin deficiency may benefit from testing before oestrogen contraception or pregnancy.

How it is confirmed

  • Test only if the result will change management, and after explaining what it can and cannot tell.
  • Do protein C, protein S and antithrombin activity after the acute clot and off warfarin; genetic tests can be done any time.
  • Lupus anticoagulant: best tested off anticoagulants or with the laboratory told which drug is present; confirm any positive antibody at 12 weeks.
  • Unusual-site clot: count, smear, JAK2, flow cytometry for PNH, antiphospholipid antibodies and an age-appropriate cancer search.

Common traps

  • Testing protein C, S or antithrombin during an acute clot or on warfarin: it can label a false deficiency for life.
  • Diagnosing APS from a single positive antibody: transient antibodies are common after infections.
  • Using a DOAC in triple-positive APS: more arterial clots than with warfarin.
  • Ordering MTHFR or broad 'thrombophilia panels': they do not change treatment but cause anxiety and wrong labels in relatives.

Test yourself

Think of the answer, then tap the question to see it.

Why should protein C and S not be measured during an acute DVT or on warfarin, while factor V Leiden can be tested any time?

Protein C and S levels fall when consumed by a clot and when warfarin blocks vitamin K; factor V Leiden is a DNA test that drugs and clots do not change.

Why does antithrombin deficiency make heparin less effective?

Heparin works by boosting antithrombin; with little antithrombin there is little for heparin to boost.

A woman has had three early pregnancy losses and her lupus anticoagulant is positive once. Does she have APS?

Not yet: the antibody must be positive again at least 12 weeks later, since transient positives are common.

A man has a hepatic vein thrombosis. Which causes should be looked for before inherited thrombophilia?

Myeloproliferative neoplasm (JAK2), PNH, antiphospholipid syndrome and cancer, which cause clots in unusual sites.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Factor V Leiden thrombophilia (MedlinePlus Genetics, US National Library of Medicine, 2023); Prothrombin thrombophilia (MedlinePlus (U.S. National Library of Medicine), 2025); Antiphospholipid syndrome: MedlinePlus Genetics (MedlinePlus Genetics, US National Library of Medicine, 2022); Hereditary antithrombin deficiency: MedlinePlus Genetics (MedlinePlus Genetics (U.S. National Library of Medicine), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.